Yamada S, Hashimoto D, Yamamoto T, Yamaki S, et al. Reconsideration of the clinical impact of neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: A dual-institution collaborative clinical study. Pancreatology 2024 Mar 26:S1424-3903(24)00073-5. doi: 10.1016/j.pan.2024.
PMID: 38548551